Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom

BACKGROUND: End-stage renal disease (ESRD) patients receiving haemodialysis (HD) are a vulnerable group of patients with increased mortality from COVID-19. Despite improved understanding, the duration of host immunity following COVID-19 infection and role of serological testing alone or in addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Wickens, Olivia, Chinnadurai, Rajkumar, Mannan, Fahmida, Svendsen, Frida, Baig, Mirza Yasar, Chukwu, Chukwuma, Ali, Ibrahim, Summersgill, Christina, Evans, Dawn, Antoine, Berckley V., Oxton, Julie, Mairs, Nathan, Flanagan, Emma, Oliver, Robert, Kalra, Philip A., Poulikakos, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075608/
https://www.ncbi.nlm.nih.gov/pubmed/33902482
http://dx.doi.org/10.1186/s12882-021-02366-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075608/
https://www.ncbi.nlm.nih.gov/pubmed/33902482
http://dx.doi.org/10.1186/s12882-021-02366-2

Ejemplares similares